Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587925 · ClinicalTrials.gov registry record · NA
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00587925: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00587925 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587925, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Bone Mineral Density (BMD) as measured by X-ray shows the amount of calcium in the bone. Low BMD may reflect osteoporosis, a condition where there is an increased risk of fracture. Women who have gone through menopause have a higher risk of getting osteoporosis because they lose calcium from their bones much faster than younger women. Women with breast cancer may have an additional risk for getting osteoporosis because of the effects of their treatment with chemotherapy. The purpose of this study is to see what levels of BMD post-menopausal women with breast cancer have, and to see if the level of BMD changes during a women's treatment after her surgery. This trial studies changes in BMD and markers of bone activity in women receiving treatment for early stage breast cancer.
Interventions
- OTHER Bone Mineral Density
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2005-03 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587925
The ClinicalTrials.gov registry entry for NCT00587925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Mineral Density is the first listed.
NCT00587925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587925 about?
NCT00587925 is a clinical study titled "Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer". Bone Mineral Density (BMD) as measured by X-ray shows the amount of calcium in the bone. Low BMD may reflect osteoporosis, a condition where there is an increased risk of fracture. Women who have gone through menopause have a higher risk of getting osteoporosis because they lose calcium from their b...
What is the current status of trial NCT00587925?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2005-03. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00587925?
The interventions under investigation include: Bone Mineral Density (OTHER).
Who is sponsoring clinical trial NCT00587925?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.